MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04723nam a22003017a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
20241101104848.0 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20241101105530.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
241101b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
978-3-030-74329-1 |
|
|---|
| International Standard Book Number |
978-3-030-74330-7 (eBook) |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
2523-8027 |
|
|---|
| International Standard Serial Number |
2523-8035 (electronic) |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
ddc |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
English |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Fuller form of name |
Muthupandian Saravanan |
| 222 ## - KEY TITLE |
|---|
| Key title |
acid antibody applications bilayer biocompatibility biological biomarkers Biomaterials biomedical breast cancer cancer cells cancer theranostics cancer therapy cancer treatment carbon carcinoma carriers cell lines cellular uptake Chemical Chemistry chemotherapy Chen clinical conjugated contrast agent Controlled Release cytotoxicity dendrimers developed diagnosis DOX doxorubicin drug delivery drug delivery systems dual-targeting effect efficacy efficient encapsulated enhanced exosomes Fig fluorescence functional gene glioma gold nanoparticles graphene H https://doi Huang hybrid hydrophobic imaging International Journal Journal of Controlled LC-MSNs ligands lipid liposomes Liu loaded magnetic membrane mesoporous silica metal-organic frameworks mice micelles MOF Molecular molecules MRI multifunctional Nano nanobodies nanocarriers nanomaterials Nanomedicine nanoparticles Nanoscale nanostructures nanosystem Nanotechnology nanotubes NIR nm NPs Oncology overexpressed oxide paclitaxel PDT PEGylated peptide pH Pharmaceutics phase photodynamic therapy photothermal therapy polymer porphyrin potential protein PTX quantum dots radiation receptor Research siRNA stability structure surface synthesis theranostic therapeutic tissue toxicity tumor tumor cells VHH vitro vivo Wang Wu Zhang |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Cancer Nanotheranostics. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Department of Pharmacology Saveetha Dental College Saveetha Institute of Medical and Technical Sciences (SIMATS) Chennai, India | |
| Name of publisher, distributor, etc. |
Springer Nature Switzerland AG | |
| Date of publication, distribution, etc. |
2021 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
362 Pages |
|
|---|
| Extent |
Includes References |
| 490 ## - SERIES STATEMENT |
|---|
| Series statement |
Nanotechnology in the Life Sciences |
| Volume/sequential designation |
Volume 1 |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Nanotechnology is an interdisciplinary research field that integrates chemistry, engineering, biology, and medicine. Nanomaterials offer tremendous opportunity as well as challenges for researchers. Of course, cancer is one of the world's most common health problems, responsible for many deaths. Exploring efficient anticancer drugs could revolutionize treatment options and help manage cancer mortality. Nanomedicine plays a significant role in developing alternative and more effective treatment strategies for cancer theranostics. This book mainly focuses on the emerging trends using nanomaterials and nanocomposites as alternative anticancer material’s. The book is divided into three main topic areas: how to overcome existing traditional approaches to combat cancer, applying multiple mechanisms to target the cancer cells, and how nanomaterials can be used as effective carriers. The contents highlight recent advances in interdisciplinary research on processing, morphology, structure, and properties of nanostructured materials and their applications to combat cancer.Cancer Nanotheranostics is comprehensive in that it discusses all aspects of cancer nanotechnology. Because of the vast amount of information, it was decided to split this material into two volumes. In the first volume of Cancer Nanotheranostics, we discuss the role of different nanomaterials for cancer therapy, including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials and nano-antibodies. In the second volume, we discuss the nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nano-erythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, the safety of nano-biomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| General subdivision |
Cancer, Medical / General, Medical / Oncology / General, Nanobiotechnology, Nanomedicine, Science / Biotechnology, Technology & Engineering / Materials Science / General, Biotechnology, Cancer -- Research, Cancer -- Treatment -- Technological innovations, Electronic books, Materials science, Nanostructured materials. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Fuller form of name |
Hamed Barabadi |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-030-74330-7 ">https://doi.org/10.1007/978-3-030-74330-7 </a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
ddc |
| Koha item type |
E-BOOKS |
| Suppress in OPAC |
|
